Top Markets
#1 Islamic Coin Islamic Coin +151.47%
#2 DOVU DOVU +48.81%
#3 Black Phoenix Black Phoenix +34.68%
#4 Velvet Velvet +29.04%
#5 Cross Cross +22.45%
#6 Akedo Akedo +17.41%
#7 DoubleZero DoubleZero +14.34%
#8 Cap Cap +11.68%
#9 Not in Employment, Education, or Training Not in Employment, Education, or Training +11.22%
#10 HOME HOME +10.23%
Coin of the day
Islamic Coin Islamic Coin
सेटिंग्स
भाषा
हिन्दी
मुद्रा
USD
थीम
Galera Therapeutics, Inc. Galera Therapeutics, Inc.

Galera Therapeutics, Inc.

GRTX
शेयरों में रैंक #33957
Galera Therapeutics, Inc. operates as a clinical-stage biopharmaceutical... Galera Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company, specializing in the creation and commercialization of therapies aimed at revolutionizing cancer radiotherapy. Its lead investigational drug, avasopasem manganese (GC4419), functions as a small molecule superoxide dismutase mimetic. This compound has successfully completed a Phase III clinical trial targeting severe oral mucositis induced by radiation therapy in head and neck cancer (HNC) patients. Furthermore, GC4419 is currently undergoing Phase IIa clinical trials for radiotherapy-induced esophagitis in lung cancer patients, as well as for HNC patients undergoing standard-of-care radiation treatment. The company is also progressing with GC4711, another superoxide dismutase mimetic candidate, which is in a Phase I/II clinical trial. This trial evaluates its combination with stereotactic body radiation therapy (SBRT) for individuals diagnosed with non-small cell lung cancer and locally advanced pancreatic cancer. Galera Therapeutics was founded in 2012 and maintains its headquarters in Malvern, Pennsylvania.
शेयर मूल्य
$17.15
अंतिम समन्वयन: 2026-08-03
मार्केट कैप
$6.51M
बदलाव (1 दिन)
9.80%
बदलाव (1 वर्ष)
289.77%
देश
US
व्यापार Galera Therapeutics, Inc. (GRTX)

श्रेणी

Healthcare
Galera Therapeutics, Inc. (GRTX) के लिए बकाया शेयरों की संख्या
March 2026 की स्थिति में बकाया शेयरों की संख्या: 98.62M
Galera Therapeutics, Inc. की नवीनतम वित्तीय रिपोर्ट और शेयर मूल्य के अनुसार, कंपनी के वर्तमान बकाया शेयरों की संख्या 98.62M है। December 2023 के अंत में कंपनी के पास 44.55M बकाया शेयर थे। बकाया शेयरों की संख्या आमतौर पर शेयर स्प्लिट्स और शेयर बायबैक से प्रभावित होती है।
Galera Therapeutics, Inc. (GRTX) के लिए 2017 से 2026 तक बकाया शेयरों का इतिहास
प्रत्येक वर्ष के अंत में बकाया शेयर
वर्ष बकाया शेयर परिवर्तन
2026 (TTM) 98.62M 80.52%
2024 54.63M 22.64%
2023 44.55M 64.47%
2022 27.09M 5.03%
2021 25.79M 3.70%
2020 24.87M 0.24%
2019 24.81M 28.15%
2018 19.36M -98.73%
2017 1.52B 0.00%
समान कंपनियों या प्रतिस्पर्धियों के लिए बकाया शेयर
कंपनी बकाया शेयर अंतर देश
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 253.90M 157.45%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 62.19M -36.95%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 0.00 -100.00%
BE